Cell lines from lymphatic system (e.g., lymphoma and myeloma) expressed relatively less TNFAIP while intermediate expression level of TNFAIP2 was observed in AML cell lines. This evidence concerns the gene TNFAIP2 and acute myeloid leukemia.